UBS Group’s Vaccinex, Inc. Common Stock VCNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $11.6K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $748 | Buy |
|
|||||
|
2023
Q4 | $225 | Sell |
|
|||||
|
2023
Q3 | $14.2K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $6.53K | Buy |
|
|||||
|
2022
Q4 | $1.38K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $0 | Sell |
|
|||||
|
2021
Q3 | $12K | Buy |
|
|||||
|
2021
Q2 | $10K | Sell |
|
|||||
|
2021
Q1 | $86K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $7K | Buy |
|
|||||
|
2020
Q1 | $1K | Sell |
|
|||||
|
2019
Q4 | $11K | Sell |
|
|||||
|
2019
Q3 | $17K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $12K | Buy |
|
|||||
|
2018
Q4 | $7K | Buy |
|
|||||
|
2018
Q3 | $5K | Buy |
|